Marshall Wace’s Antares Pharma, Inc. ATRS Stock Holding History

Marshall Wace’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-275,284	Closed	-$1.13M	–	4066
2022 Q1	$1.13M	Buy	+275,284	New	+$999K	﹤0.01%	2397
2021 Q1	–	Sell	-95,522	Closed	-$381K	–	3017
2020 Q4	$381K	Sell	95,522 -138,205	-59%	-$447K	﹤0.01%	1592
2020 Q3	$631K	Sell	233,727 -260,094	-53%	-$720K	﹤0.01%	1170
2020 Q2	$1.36M	Sell	493,821 -331,240	-40%	-$924K	0.01%	916
2020 Q1	$1.95M	Buy	825,061 +136,440	+20%	+$464K	0.02%	642
2019 Q4	$3.24M	Buy	688,621 +334,189	+94%	+$1.37M	0.02%	670
2019 Q3	$1.18M	Sell	354,432 -734,225	-67%	-$2.42M	0.01%	903
2019 Q2	$3.58M	Sell	1,088,657 -220	-0%	-$636	0.03%	595
2019 Q1	$3.3M	Buy	1,088,877 +220	+0%	+$713	0.03%	590
2018 Q4	$2.96M	Buy	1,088,657 +1,037,693	+2,036%	+$3.42M	0.03%	627
2018 Q3	$171K	Buy	+50,964	New	+$157K	﹤0.01%	1080

Other funds holding ATRS

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Marshall Wace's ATRS Position: Q2 2022 in Review

Marshall Wace sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 275,284 shares — an estimated $1.13M sold.

Marshall Wace first reported a position in ATRS in Q3 2018 and held it in 11 quarters. The position peaked at $3.58M in Q2 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Marshall Wace reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Marshall Wace sold 275,284 Antares Pharma, Inc. shares in Q2 2022, an estimated $1.13M.
Marshall Wace first reported a position in Antares Pharma, Inc. in Q3 2018 and held it in 11 quarters.
Marshall Wace's Antares Pharma, Inc. position peaked at $3.58M in Q2 2019.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.